BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener Research
Sign in Register

NGEN

NervGen Pharma Corp. Common stock NASDAQ Listed Feb 8, 2021
$2.09
Pre-mkt $2.14 +2.50%
Mkt Cap $171.8M
52w Low $1.70 8.5% of range 52w High $6.30
50d MA $2.81 200d MA $3.57
P/E (TTM)
EV/EBITDA
P/B 43.5x
Debt/Equity 0.0x
ROE
P/FCF -7.8x
RSI (14) 65.80
ATR (14) $0.17
Beta 0.99
50d MA $2.81
200d MA $3.57
Avg Volume 1.4M
NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.
SIC Code
2834
CIK (SEC)
Phone
604-336-8089
1455 Bellevue Avenue, Suite 301 · West Vancouver, BC V7T 1C3 · CA
Data updated apr 26, 2026 2:55pm · Source: financialmodelingprep.com